全文获取类型
收费全文 | 2599094篇 |
免费 | 201150篇 |
国内免费 | 6345篇 |
专业分类
耳鼻咽喉 | 34870篇 |
儿科学 | 86175篇 |
妇产科学 | 73007篇 |
基础医学 | 375140篇 |
口腔科学 | 74916篇 |
临床医学 | 241423篇 |
内科学 | 500057篇 |
皮肤病学 | 54237篇 |
神经病学 | 213454篇 |
特种医学 | 99193篇 |
外国民族医学 | 804篇 |
外科学 | 378118篇 |
综合类 | 62360篇 |
现状与发展 | 4篇 |
一般理论 | 958篇 |
预防医学 | 212749篇 |
眼科学 | 59023篇 |
药学 | 194528篇 |
9篇 | |
中国医学 | 5428篇 |
肿瘤学 | 140136篇 |
出版年
2018年 | 27418篇 |
2017年 | 21036篇 |
2016年 | 23195篇 |
2015年 | 26655篇 |
2014年 | 36749篇 |
2013年 | 56750篇 |
2012年 | 77223篇 |
2011年 | 81871篇 |
2010年 | 48043篇 |
2009年 | 45078篇 |
2008年 | 76577篇 |
2007年 | 80859篇 |
2006年 | 81494篇 |
2005年 | 79105篇 |
2004年 | 76703篇 |
2003年 | 73179篇 |
2002年 | 71532篇 |
2001年 | 116993篇 |
2000年 | 120890篇 |
1999年 | 102054篇 |
1998年 | 28855篇 |
1997年 | 26231篇 |
1996年 | 25959篇 |
1995年 | 25084篇 |
1994年 | 23566篇 |
1993年 | 22260篇 |
1992年 | 83416篇 |
1991年 | 81622篇 |
1990年 | 79445篇 |
1989年 | 76293篇 |
1988年 | 70972篇 |
1987年 | 69644篇 |
1986年 | 66415篇 |
1985年 | 63953篇 |
1984年 | 48091篇 |
1983年 | 41302篇 |
1982年 | 24693篇 |
1981年 | 21985篇 |
1979年 | 45121篇 |
1978年 | 31714篇 |
1977年 | 26535篇 |
1976年 | 25346篇 |
1975年 | 26569篇 |
1974年 | 32468篇 |
1973年 | 31439篇 |
1972年 | 28938篇 |
1971年 | 27170篇 |
1970年 | 25043篇 |
1969年 | 23257篇 |
1968年 | 21754篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
992.
Is vasoactive intestinal polypeptide the principal transmitter involved in human penile erection? 总被引:5,自引:0,他引:5
Previous work from this laboratory reported on the effects of several autacoids and other agents on strips of human corpus cavernosum (cc) muscle. These investigations indicated the presence in the cc muscle of a) atropine-sensitive cholinoceptors, b) alpha- and beta-adrenoceptors and c) a non-adrenergic non-cholinergic mechanism. Several recent publications have presented evidence in support of the possibility that vasoactive intestinal polypeptide (VIP) is an important, or the chief, transmitter in human penile erection. This paper describes the actions of VIP and other compounds on the cc muscle and the effect of intracavernous injection of VIP in volunteers. Among the agents tested, VIP was the most potent relaxant of the cc muscle. This effect, which was seen at a dose as low as 0.03 nM, was suppressed by VIP antiserum. The response of the isolated penile vasculature to VIP was similar. VIP antiserum had no effect on the relaxation of the cc muscle produced by field stimulation. In five of the seven subjects given intracavernous VIP (1.0 micrograms.) some degree of penile enlargement was evident, but none had an erection. It is suggested that local release of VIP, withdrawal of the alpha-adrenoceptor mediated tonic supply to the penis and the activation of the latter's beta-adrenoceptors are all probably involved in penile erection in man. 相似文献
993.
994.
A W Biglan R Gonnering L B Lockhart B Rabin F H Fuerste 《American journal of ophthalmology》1986,101(2):232-235
To test the possibility of the formation of an antibody to botulinum A toxin after multiple injections of this potent neurotoxin, we collected serum samples from 28 patients who received 57 doses. These injections over a nine-month period with as much as 50 units per injection formed no detectable antibody. 相似文献
995.
996.
997.
998.
999.
K Thomsen B J Riis J S Johansen C Christiansen P R?dbro 《Gynecological endocrinology》1987,1(2):169-175
Bone turnover before and after withdrawal of estrogen/gestagen treatment was studied in a randomized trial with 110 healthy female volunteers, who had passed a natural menopause 6 months to 3 years before the start of the study. Urinary excretion of intravenously injected 99m-technetium diphosphonate was measured as an index of bone turnover; plasma bone Gla protein and serum alkaline phosphatase were measured as indices of bone formation; and fasting urinary excretion of hydroxyproline and calcium were measured as estimates of bone resorption. During 2 years of hormone treatment, all variables decreased highly significantly (p less than 0.001) to a constant low level. Three months after withdrawal all variables increased highly significantly (p less than 0.001) towards, but not above, pretreatment and placebo levels. We conclude that withdrawal of estrogen/gestagen replacement therapy in postmenopausal women increases bone turnover, but not in excess of pretreatment values. This indicates that bone loss (after withdrawal) is similar to that seen in the placebo group and that a rebound phenomenon is unlikely. 相似文献
1000.
The authors report the results of the Patterns of Care for Brachytherapy in Europe (PCBE) throughout France. Responses were obtained for 91% of the Radiation Oncology departments, which have declared using brachytherapy for 67, and gave detailed data for 49 ones. The equipments and treated tumours were recorded. LDR brachytherapy remained the most often used (53.5%), followed by HDR (28%). PDR represented 5.5% and permanent implants 11%. The authors discuss the development of new equipment, with an aggregation of the structures, and an increase of the PDR and prostate implants use. 相似文献